Gadobenate dimeglumine-enhanced MRI of the breast: Analysis of dose response and comparison with gadopentetate dimeglumine

American Journal of Roentgenology

Volumn 181, Issue 3, 2003, Pages 663-676

  Knopp, Michael V ^a,b   Bourne, Michael W ^c   Sardanelli, Francesco ^d   Wasser, Martin N ^e   Bonomo, Lorenzo ^f   Boetes, Carla ^g   Müller Schimpfle, Markus ^h   Hall Craggs, Margaret A ⁱ   Hamm, Bernd ^j   Orlacchio, Antonio ^k   Bartolozzi, Carlo ^l   Kessler, Mareike ^m   Fischer, Uwe ⁿ   Schneider, Günther ^o   Oudkerk, Matthijs ^p   Teh, William L ^q   Gehl, Hans Björn ^r   Salerio, Isabella ^s   Pirovano, Gianpaolo ^s   La Noce, Anna ^s   Kirchin, Miles A ^s   Spinazzi, Alberto ^s   more..

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^d Servizio di Radiologia   (Italy)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Ospedale Clinicizzato SS Annunziata   (Italy)

^g RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^h UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

ⁱ MIDDLESEX HOSPITAL   (United Kingdom)

^j CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^k FATEBENEFRATELLI HOSPITAL   (Italy)

^l Instituto di Radiologia   (Italy)

^m LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

ⁿ UNIVERSITY OF GÖTTINGEN   (Germany)

^o SAARLAND UNIVERSITY   (Germany)

^p UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^q NORTHWICK PARK HOSPITAL   (United Kingdom)

^r UNIVERSITY OF LÜBECK   (Germany)

^s Bracco Imaging SpA   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GADOBENATE DIMEGLUMINE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; BOLUS INJECTION; BREAST CARCINOMA; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEADACHE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; MAJOR CLINICAL STUDY; MORPHOLOGY; MULTICENTER STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY ANALYSIS; SIDE EFFECT; THREE DIMENSIONAL IMAGING;

EID: 0042890596     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/ajr.181.3.1810663     Document Type: Article

References (42)

1. Greenlee RT, Hill-Harmon MB, Murray T, Thun M. Cancer statistics, 2001. CA Cancer J Clin 2001;51:15-36
2. Samuels JR, Haffty BG, Lee CH, Fischer DB. Breast conservation therapy in patients with mammographically undetected breast cancers. Radiology 1992;185:425-427
3. Leibman AJ, Kruse B. Breast cancer: mammographic and sonographic findings after augmentation mammoplasty. Radiology 1990;174:195-198
4. Jackson VP, Hendrick RE, Feig SA, Kopans DB. Imaging of the radiographically dense breast. Radiology 1993;188:297-301
5. Mendelson EB, Evaluation of the post-operative breast. Radiol Clin North Am 1992;20:107-138
6. Stelling CB. MR imaging of the breast for cancer evaluation: current status and future directions. Radiol Clin North Am 1995;33:1187-1204
7. Kelcz F, Santyr G. Gadolinium-enhanced breast MRI. Crit Rev Diagn Imaging 1995;36:287-338
8. Helbich TH. Contrast-enhanced magnetic resonance imaging of the breast. Eur J Radiol 2000;34:208-219
9. Kuhl CK. MRI of breast tumors. Eur Radiol 2000;10:46-58
10. Rankin SC. MRI of the breast. Br J Radiol 2000;73:806-818
11. Kuhl CK, Schild HH. Dynamic image interpretation of the breast. J Magn Reson Imaging 2000;12:965-974
12. Morris EA. Review of breast MRI: indications and limitations. Semin Roentgenol 2001;36:226-237
13. Orel SG, Schnall MD. MR imaging of the breast for the detection, diagnosis and staging of breast cancer. Radiology 2001;220:13-30
14. Morris EA. Breast cancer imaging with MRI. Radiol Clin North Am 2002;40:443-466
15. Tilanus-Linthorst MM, Obdeijn IM, Bartels KC, de Koning HJ, Oudkerk M. First experiences in screening women at high risk for breast cancer with MR imaging. Breast Cancer Res Treat 2000;63:53-60
16. Stoutjesdijk MJ, Boetes C, Jager GJ, et al. Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer. J Natl Cancer Inst 2001;93:1095-1102
17. Warner E, Plewes DB, Shumak RS, et al. Comparison of breast magnetic resonance imaging, mammography and ultrasound for surveillance of women at high risk for hereditary breast cancer. J Clin Oncol 2001;19:3524-3531
18. Piccoli CW. Contrast-enhanced breast MRI: factors affecting sensitivity and specificity. Eur Radiol 1997;7[suppl 5]:S281-S288
19. Boetes C, Barentsz JO, Mus RD, et al. MR characterization of suspicious breast lesions with a gadolinium-enhanced turboFLASH subtraction technique. Radiology 1994;193:777-781
20. Stomper PC, Herman S, Klippenstein DL, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995;197:387-395
21. Liu PF, Debatin JF, Caduff RF, Kacl G, Garzoli E, Krestin GP. Improved diagnostic accuracy in dynamic contrast-enhanced MRI of the breast by combined quantitative and qualitative analysis. Br J Radiol 1998;71:501-509
22. Khatri VP, Stuppino JJ, Espinosa MH, Pollack MS. Improved accuracy in differentiating malignant from benign mammographic abnormalities: a simple, improved magnetic resonance imaging method. Cancer 2001;92:471-478
23. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat 2001;68:45-54
24. White-Nunes L, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology 2001;219:484-494
25. Kirchin MA, Pirovano G, Spinazzi A. Gadobenate dimeglumine (Gd-BOPTA): an overview. Invest Radiol 1998;33:798-809
26. Cavagna FM, Maggioni F, Castelli PM, et al. Gadolinium chelates with weak binding to serum proteins: a new class of high-efficiency, general purpose contrast agents for magnetic resonance imaging. Invest Radiol 1997;32:780-796
27. de Haën C, Cabrini M, Akhnana L, Ratti D, Calabi L, Gozzini L. Gadobenate dimeglumine 0.5 M solution for injection (MultiHance): pharmaceutical formulation and physicochemical properties of a new magnetic resonance imaging contrast medium. J Comput Assist Tomogr 1999;23[suppl 1]:S161-S168
28. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving nonhuman subjects, revised. Edinburgh: World Medical Association, 2000
29. Gilles R, Guinebretiere JM, Lucidarme O, et al. Nonpalpable breast tumors: diagnosis with contrast enhanced subtraction dynamic MR imaging. Radiology 1994;191:625-631
30. Orel SG, Schnall MD, LiVolsi VA, Troupin RH. Suspicious breast lesions: MR imaging with radiologic-pathologic correlation. Radiology 1994;190:485-493
31. Heywang-Köbrunner SH, Haustein J, Pohl C, et al. Contrast-enhanced MR imaging of the breast: comparison of two different doses of gadopentetate dimeglumine. Radiology 1994;191:639-646
32. Heiberg EV, Perman WH, Herrmann VM, Janney CG. Dynamic sequential 3D gadolinium-enhanced MRI of the whole breast. Magn Reson Imaging 1996;14:337-348
33. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of pre-operative contrast-enhanced MR imaging on the therapeutic approach. Radiology 1999;213:881-888
34. Helbich TH, Roberts TPL, Gossmann A, et al. Quantitative gadopentetate-enhanced MRI of breast tumors: testing of different analytic methods. Magn Reson Med 2000;44:915-924
35. Mussurakis S, Buckly DL, Coady AM, Turnbull LW, Horsman A. Observer variability in the interpretation of contrast enhanced MRI of the breast. Br J Radiol 1996;69:1009-1016
36. Heywang-Köbrunner SH, Viehweg P, Heinig A, Kuchler C. Contrast-enhanced MRI of the breast: accuracy, value, controversies, solutions. Eur J Radiol 1997;24:94-108
37. Coulthard A, Potterton AJ. Pitfalls of breast MRI. Br J Radiol 2000;73:665-671
38. Heywang-Köbrunner SH, Bick U, Bradley WG Jr, et al. International investigation of breast MRI: results of a multicentre study (11 sites) concerning diagnostic parameters for contrast-enhanced MRI based on 519 histopathologically correlated lesions. Eur Radiol 2001;11:531-546
39. Kinkel K, Hylton NM. Challenges to interpretation of breast MRI. J Magn Reson Imaging 2001;13:821-829
40. Kinkel K, Helbich TH, Esserman LJ, et al. Dynamic high-spatial-resolution MR imaging of suspicious breast lesions: diagnostic criteria and interobserver variability. AJR 2000;175:35-43
41. Knopp MV, Weiss E, Sinn HP, et al. Pathophysiologic basis of contrast enhancement in breast tumors. J Magn Reson Imaging 1999;14:260-266
42. Kirchin MA, Pirovano G, Venetianer C, Spinazzi A. Safety assessment of gadobenate dimeglumine (MultiHance): extended clinical experience from phase I studies to post-marketing surveillance. J Magn Reson Imaging 2001;14:281-294